Ignite Creation Date:
2025-12-24 @ 10:14 PM
Ignite Modification Date:
2026-01-03 @ 11:02 AM
Study NCT ID:
NCT01908335
Status:
COMPLETED
Last Update Posted:
2014-10-20
First Post:
2013-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C
Sponsor:
Beijing Kawin Technology Share-Holding Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KAWIN-002-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None